Hansa Biopharma announces positive reimbursement decision in Italy for Idefirix® (imlifidase) as desensitization treatment for highly sensitized patients in kidney transplantation ...Middle East

Idefirix® is granted full access and reimbursement in line with the indication approved by the European Medicines Agency (EMA).1 The decision by the Italian Medicine Agency (AIFA) provides highly sensitized patients in Italy with the opportunity to receive Idefirix® to enable kidney...

Hence then, the article about hansa biopharma announces positive reimbursement decision in italy for idefirix imlifidase as desensitization treatment for highly sensitized patients in kidney transplantation was published today ( Thursday 08/12/2022 - 10:28 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Hansa Biopharma announces positive reimbursement decision in Italy for Idefirix® (imlifidase) as desensitization treatment for highly sensitized patients in kidney transplantation )

Also on site :

• Suspect in deadly San Jose police shooting identified
• Details emerge in crime spree that ended in deadly shootout with San Jose police
• Grey's Anatomy Brings Back Meredith And Nick For A Tense Reunion — And A Big Question About Their Future